These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation. Lee KH, Park HW, Lee N, Hyun DY, Won J, Oh SS, Park HJ, Kim Y, Cho JY, Kim MC, Sim DS, Yoon HJ, Yoon NS, Kim KH, Hong YJ, Kim JH, Ahn Y, Jeong MH, Park JC, Cho JG. Europace; 2017 Dec 01; 19(suppl_4):iv1-iv9. PubMed ID: 29220421 [Abstract] [Full Text] [Related]
5. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Villines TC, Schnee J, Fraeman K, Siu K, Reynolds MW, Collins J, Schwartzman E. Thromb Haemost; 2015 Nov 25; 114(6):1290-8. PubMed ID: 26446456 [Abstract] [Full Text] [Related]
7. Risk of bleeding with dabigatran in atrial fibrillation. Hernandez I, Baik SH, Piñera A, Zhang Y. JAMA Intern Med; 2015 Jan 25; 175(1):18-24. PubMed ID: 25365537 [Abstract] [Full Text] [Related]
8. Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study. Cheung CL, Sing CW, Lau WCY, Li GHY, Lip GYH, Tan KCB, Cheung BMY, Chan EWY, Wong ICK. Cardiovasc Diabetol; 2021 Mar 25; 20(1):71. PubMed ID: 33766030 [Abstract] [Full Text] [Related]
13. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation. Palamaner Subash Shantha G, Bhave PD, Girotra S, Hodgson-Zingman D, Mazur A, Giudici M, Chrischilles E, Vaughan Sarrazin MS. Circ Cardiovasc Qual Outcomes; 2017 Apr 25; 10(4):. PubMed ID: 28408716 [Abstract] [Full Text] [Related]
14. Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis. Koretsune Y, Yamashita T, Yasaka M, Ono Y, Hirakawa T, Ishida K, Kuroki D, Sumida T, Urushihara H. J Cardiol; 2019 Mar 25; 73(3):204-209. PubMed ID: 30477926 [Abstract] [Full Text] [Related]
18. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND. BMJ; 2015 Apr 24; 350():h1857. PubMed ID: 25910928 [Abstract] [Full Text] [Related]
19. The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation. Harel Z, McArthur E, Jeyakumar N, Sood MM, Garg AX, Silver SA, Dorian P, Blum D, Beaubien-Souligny W, Yan AT, Badve SV, Smyth B, Jun M, Jandoc R, Kitchlu A, Wald R. Clin J Am Soc Nephrol; 2021 Oct 24; 16(10):1470-1479. PubMed ID: 34407990 [Abstract] [Full Text] [Related]